Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial

Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-29T12:23:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include new details about the study on Crohn's disease, specifically regarding the treatment protocol with risankizumab, and the involvement of Boehringer Ingelheim as a collaborator. Additionally, the revision number has been updated to v2.15.0.
    Difference
    16%
    Check dated 2025-04-22T04:17:51.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-07T15:13:10.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-31T11:21:35.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-23T12:48:40.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.6%
    Check dated 2025-02-09T07:14:17.000Z thumbnail image

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.